Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- no data
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was performed similarly to the OECD 471 Guideline with acceptable restrictions.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 993
- Report date:
- 1993
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- : no certificate of analysis, no historical control data, no true assessment of the cytotoxicity, only 2 plates/concentration, only the pre-incubation method is used, no indication on the precipitation.
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Reaction mass of N-[2-(2-oxoimidazolidin-1-yl)ethyl]methacrylamide and methacrylic acid
- IUPAC Name:
- Reaction mass of N-[2-(2-oxoimidazolidin-1-yl)ethyl]methacrylamide and methacrylic acid
- Test material form:
- other: amber liquid at room temperature
- Details on test material:
- - Name of test material (as cited in study report): Mixture of N-[2-(2-oxo-1-imidazolidinyl)ethyl]methacrylamide and methacrylic acid, other name: WAM II
- Stability under test conditions: stable for 28 days in the dark, at ambient temperature
Constituent 1
Method
- Target gene:
- Histidine gene for S. typhimurium strain, Trptophan for E. coli strain
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Additional strain / cell type characteristics:
- other: additional mutations in rfa and uvrB genes. For the strains TA98, TA100 and WP2 uvrA presence of an additional plasmid pKM101 in order to enhance their sensitivity of detection of some mutagens. See Table 7.6.1/1
- Metabolic activation:
- with and without
- Metabolic activation system:
- Self-produced S9 fraction by induction of male SD rats' liver with administration of PB and 5,6-BF directly to stomach
- Test concentrations with justification for top dose:
- The amount used for the test was calculated as concentration of N-[2-(2-oxo-1-imidazolidinyl)ethyl]methacrylamide.
preliminary study: 0; 50; 100; 200; 500; 1000; 2000 and 5000 µg/plate
Main test: 313; 625; 1250; 2500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: no data
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- other: 2-(2-furyl)-3(5-nitro-2-furyl)acrylamide (AF-2); 2-methoxy-6-chloro-9-[3-(2-chloroehyl)-aminopropylamino]acridine.2HCl (ICR-191) and 2-aminoanthracene (2AA)
- Remarks:
- see details in table 7.6.1/2
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period:20 min
- Exposure duration: 48h
- Expression time (cells in growth medium): 48h
- Selection time (if incubation with a selection agent): not applicable
- Fixation time (start of exposure up to fixation or harvest of cells): not applicable
SELECTION AGENT (mutation assays): not applicable
SPINDLE INHIBITOR (cytogenetic assays): not applicable
STAIN (for cytogenetic assays): not applicable
NUMBER OF REPLICATIONS: 2 plates(triplicate for the negative control), 2 independant experiments
NUMBER OF CELLS EVALUATED: not applicable
DETERMINATION OF CYTOTOXICITY
- Method: no data - Evaluation criteria:
- no data
- Statistics:
- no data
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- See details in Table 7.6.1/3 to 7.6.1/6
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- As there was no decrease in the number of revertant, the test item can be considered as non cytotoxic.
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- See details in Table 7.6.1/3 to 7.6.1/6
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- As there was no decrease in the number of revertant, the test item can be considered as non cytotoxic.
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- See details in Table 7.6.1/3 to 7.6.1/6
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- As there was no decrease in the number of revertant, the test item can be considered as non cytotoxic.
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- See details in Table 7.6.1/3 to 7.6.1/6
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- As there was no decrease in the number of revertant, the test item can be considered as non cytotoxic.
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- See details in Table 7.6.1/3 to 7.6.1/6
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- As there was no decrease in the number of revertant, the test item can be considered as non cytotoxic.
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Water solubility: > 50%
no other data
RANGE-FINDING/SCREENING STUDIES:the range-finding study was performed in the same conditions as the main study, the number of revertants was calculated by the mean of the 3 replicate plates perfomed for each concentration of test item. The range of concentration of the preliminary study is broader than in the main study. Thus, this preliminary can be considered as a mutagenic experiment as such.
COMPARISON WITH HISTORICAL CONTROL DATA: no historical control data
ADDITIONAL INFORMATION ON CYTOTOXICITY: no data - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 7.6.1/3:Number of revertants per plate in the absence of metabolic activation in the first test
Test item Concentration |
TA 1535 |
TA1537 |
TA 98 |
TA 100 |
WP2 uvrA |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
|
0 |
14 |
12 |
25 |
139 |
37 |
50 |
15 |
15 |
19 |
142 |
47 |
100 |
15 |
9 |
28 |
155 |
40 |
200 |
10 |
7 |
21 |
127 |
38 |
500 |
15 |
9 |
21 |
151 |
52 |
1000 |
8 |
9 |
24 |
151 |
47 |
2000 |
12 |
11 |
25 |
144 |
38 |
5000 |
11 |
8 |
20 |
138 |
53 |
Positive control** |
259 |
1685 |
513 |
916 |
458 |
$: Mean of triplicate
**Mutagens positive controls:
- NaN3(0.5 µg/plate) in TA1535 strain
- ICR-191 (1 µg/plate) in TA1537 strain
- AF-2 (0.01 µg/plate) in TA 100 and WP2 uvrA strains
- AF-2 (0.1 µg/plate) in TA 98 strain
Table 7.6.1/4: Number of revertants per plate in the presence of metabolic activation (S9 mix) in the first test
Test item Concentration |
TA 1535 |
TA1537 |
TA 98 |
TA 100 |
WP2 uvrA |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
|
0 |
13 |
17 |
36 |
144 |
50 |
50 |
9 |
19 |
37 |
144 |
52 |
100 |
14 |
18 |
34 |
161 |
54 |
200 |
9 |
20 |
36 |
129 |
49 |
500 |
13 |
15 |
40 |
145 |
54 |
1000 |
11 |
15 |
43 |
143 |
61 |
2000 |
15 |
21 |
30 |
147 |
61 |
5000 |
14 |
26 |
47 |
203 |
58 |
Positive control** |
202 |
172 |
200 |
948 |
547 |
$: Mean of triplicate
**Mutagens positive controls:
- 2AA (2 µg/plate) in TA1537 and TA1535 strains
- 2AA (1 µg/plate) in TA100 strain
- 2AA (0.5 µg/plate) in TA98 strain
- 2AA (10 µg/plate) in WP2 uvrA strain
Table 7.6.1/5: Number of revertants per plate in the absence of metabolic activation in the second test
Test item Concentration |
TA 1535 |
TA1537 |
TA 98 |
TA 100 |
WP2 uvrA |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
|
0 |
13 |
7 |
23 |
110 |
36 |
313 |
9 |
8 |
28 |
124 |
43 |
625 |
12 |
8 |
31 |
131 |
34 |
1250 |
10 |
11 |
20 |
123 |
39 |
2500 |
16 |
13 |
16 |
122 |
42 |
5000 |
12 |
11 |
27 |
130 |
42 |
Positive control** |
257 |
1414 |
488 |
511 |
510 |
$: Mean of triplicate
**Mutagens positive controls:
- NaN3(0.5 µg/plate) in TA1535 strain
- ICR-191 (1 µg/plate) in TA1537 strain
- AF-2 (0.01 µg/plate) in TA 100 and WP2 uvrA strains
- AF-2 (0.1 µg/plate) in TA 98 strain
Table 7.6.1/6: Number of revertants per plate in the presence of metabolic activation (S9 mix) in the second test
Test item Concentration |
TA 1535 |
TA1537 |
TA 98 |
TA 100 |
WP2 uvrA |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
Mean$ |
|
0 |
11 |
20 |
38 |
122 |
43 |
313 |
12 |
17 |
26 |
131 |
47 |
625 |
14 |
18 |
29 |
142 |
53 |
1250 |
12 |
12 |
29 |
133 |
40 |
2500 |
12 |
16 |
44 |
143 |
39 |
5000 |
16 |
19 |
46 |
147 |
51 |
Positive control** |
121 |
89 |
232 |
587 |
352 |
$: Mean of triplicate
**Mutagens positive controls:
- 2AA (2 µg/plate) in TA1537 and TA1535 strains
- 2AA (1 µg/plate) in TA100 strain
- 2AA (0.5 µg/plate) in TA98 strain
- 2AA (10 µg/plate) in WP2 uvrA strain
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Under the test conditions, Reaction mass of methacrylic acid and N-[2-(2-oxoimidazolidin-1-yl)ethyl]methacrylamide did not show any mutagenic activity in the bacterial reverse mutation test using Salmonella typhimurium and E. coli. - Executive summary:
In a reverse gene mutation assay in bacteria, performed according to the OECD No.471 guideline, Reaction mass of methacrylic acid and N-[2-(2-oxoimidazolidin-1-yl)ethyl]methacrylamide diluted in water was tested in S. typhimurium TA1535, TA1537, TA100, TA98 and E. coli WP2 uvrA in the presence and the absence of mammalian metabolic activation (S9) using the preincubation method. The amount used for the test was calculated as concentration of N-[2-(2-oxo-1-imidazolidinyl)ethyl]methacrylamide (48.61%). Six known mutagens (Sodium azide; 2-(2-furyl)-3(5-nitro-2-furyl)acrylamide (AF-2); 2-methoxy-6-chloro-9-[3-(2-chloroehyl)-aminopropylamino]acridine.2HCl (ICR-191) and 2-aminoanthracene (2AA)) were used to check the sensitivity of the test system. They gave appropriate response, therefore the test was considered as valid.
In the first assay the test item was used at the following concentration: 0; 50; 100; 200; 500; 1000; 2000 and 5000 µg/plate (duplicate). There was a slight increase in the number of revertants in the TA98, TA100 and TA1537 strains with S9 mix at the highest dose, but this increase did not exceed twice the negative control (<1.5). Therefore it was not considered as relevant regarding the mutagenicity. For the other conditions, there was no increase in the number of revertants compared to the negative control.
In the second assay the test item was used at the following concentration: 313; 625; 1250; 2500 and 5000 µg/plate (duplicate). There was a slight increase in the number of revertants in the TA1537 without S9 mix at 2500 µg/plate, but the mean revertants did not exceed twice the mean obtained for the negative control and there was no dose-response relationship. Therefore it was not considered as relevant regarding the mutagenicity. For the other conditions, there was no increase in the number of revertants compared to the negative control.
As there was no decrease in the number of revertants compared to the negative control, the test item can be considered as non cytotoxic up to the recommended limit concentration of 5000 µg/plate.
Under the test conditions, Reaction mass of methacrylic acid and N-[2-(2-oxoimidazolidin-1-yl)ethyl]methacrylamide did not show any mutagenic activity in the bacterial reverse mutation test using Salmonella typhimurium and E. coli. This study is considered as acceptable as it satisfied the criteria of the OECD Guideline No. 471.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.